Page 11 - Pharma

Lupin receives US FDA nod for generic Evoxac capsule

Evoxac capsule, marketed by Daiichi Sankyo, had recorded sales of $ 40.8 million in the US

PerkinElmer divests medical imaging business to Varian

The business supplies flat panel X-ray detectors for medical & dental X-ray imaging systems

Zydus Healthcare buys six brands from MSD

Acquired brands belong to men's health, women's health, cardiovascular & wound management segments

Asahi Glass acquires CMC Biologics

CMC Biologics is one of the leading contract development & manufacturing organisations

AdvaMed disappointed with DoP's decision to include stents in DPCO

The US-based medical tech association AdvaMed feels that the move hinders the fundamental right of a

Sun Pharma acquires Novartis' oncology brand Odomzo for $175 mn

Acquisition of Odomzo (sonidegib), which has marketing approval in over 30 countries including US, E

Philips Healthcare to raise output of Pune facility

The company also aims to widen R&D activities of its healthcare innovation center (HIC) in Pune

Opto Circuits bags Rs 91 crore order from Philips Healthcare

As per the long term contract, the company will supply various types of medical devices to Philips Healthcare

Glenmark to enhance R&D activity and focus on specialty products for growth

The company is targeting 30 percent of total revenues from specialty and innovation segments over the next decade

Cipla receives US FDA's approval for generic Tricor tablet

Tricor (fenofibrate) tablet and generic equivalents had US sales of approximately $ 307 million for the 12 month period ending October 2016, according to IMS Health

Lupin launches anti-fungal drug voriconazole in US

Voriconazole tablet and oral suspension are generic versions of Vfend tablet and Vfend oral suspension - manufactured by PF Prism CV

Baxter acquires Claris Injectables for $625 million

With this acquisition, the US-based pharma company will add global portfolio of sterile injectables, robust pipeline, and manufacturing capabilities

Lonza buys gelatin capsules maker Capsugel from KKR for $ 5.5 billion

With 13 facilities, which include a hard capsule manufacturing facility in Delhi (India), Capsugel is one of the leading global players in advanced oral dosage delivery technologies

Cipla to set up manufacturing facility for pharmaceuticals in Iran

For this, the company has agreed to form a joint venture with Iran's Ahran Tejarat Company with an investment of approximately Euro 16.875 million (about Rs 120 crore)

Alkem's Ankleshwar APIs facility receives three 483 observations from US FDA

These observations were issued following an inspection conducted by US FDA at the site from December 5-9, 2016

Lonza in talks with KKR to buy Capsugel

If the deal materialises, then experts believe that it would be worth more than $ 5 billion

Natco launches generic Tamiflu capsule in US

Tamiflu oral capsules had US sales of approximately $ 403 million for twelve months ending December 2015, according to IMS Health

Glenmark launches first generic version of Zetia in US

The company and its partner, Endo, will be entitled to 180 days of generic drug exclusivity for ezetimibe, which is used for the treatment of high cholesterol

What is the way forward for Indian vaccine industry?

While Indian vaccine producers dominate global market, bulk of marketshare in the high-value domestic private market is held by a few MNCs, says Pushpa Vijayraghavan and Aparna Balasubramanian

Sun Pharma to partner with Israel's Moebius Medical for osteoarthritis drug

As per the licensing deal, Sun Pharma will have worldwide commercialisation & manufacturing rights for MM-II, a candidate for the treatment of pain in osteoarthritis